Aurora Pharmaceutical Inc. announced today that the FDA has approved its exclusive vented draw-off dosing cap. It is now included with every purchase of Altren (altrenogest) Solution 0.22% Aurora ...
-The INSPIRE Trial Is Designed to Assess the Ability of CAP-1002 to Modulate the Cytokine Storm Associated With Severe COVID-19- LOS ANGELES, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results